At A Glance
Pharma marketers need privacy-first identity workflows that keep DTC and HCP paths separate while connecting activation and measurement. Experian’s pharma marketing playbook shows how brands can prepare audiences, coordinate approved destinations, and build measurement into the workflow so teams can connect media exposure to trusted outcomes.Pharma marketers need to build more meaningful relationships with patients (DTC), caregivers, and healthcare professionals (HCP) across a health journey that spans many channels, partners, and decision moments.
That creates an operational challenge. Data, activation, and measurement often sit with different vendors, each with its own rules, IDs, and handoffs. DTC and HCP campaigns need separate identity paths, but both still need to support the same brand objective. Pharma marketing teams need a clearer way to connect audience strategy, media exposure, and outcomes without adding risk or confusion. That starts with identity, not as a single system for every audience, but as a governed workflow that keeps DTC and HCP paths separate and coordinated.
In our pharma marketing playbook, “From onboarding to outcomes: The privacy-first independent identity workflow for pharma marketing,” we show pharma brands how to build privacy-first workflows that connect identity, activation, and measurement across the healthcare ecosystem.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
Here are three priorities pharma marketing teams can use to build more governed, measurable engagement.
1. Why should pharma marketers keep DTC and HCP identity workflows separate?
Pharma marketers should keep DTC and HCP identity workflows separate because each audience requires different data signals, activation paths, and measurement methods. Separate workflows give teams clearer governance controls while helping DTC and HCP campaigns support the same brand objective.
DTC and HCP campaigns often support the same brand objective, but they need separate ways to manage data, reach audiences, and measure results. That’s where identity plays a central role. It gives pharma teams a governed way to keep DTC and HCP data, activation, and measurement separate while coordinating both toward the same goal, like driving drug awareness and impacting prescribing behavior.
The missing layer in pharma marketing. Watch our Q&A
DTC activation depends on privacy-safe identity, which can include tokenization, aggregated audience logic, and non-clinical consumer context. This helps brands better understand patients and caregivers as people, not only as condition-defined audiences.
HCP activation depends on a different foundation. It may use signals such as National Provider Identifier (NPI), specialty, practice location, partner identifiers, and other verified attributes. When DTC and HCP workflows are treated as one system, you can create governance risk, weaken audience logic, and make measurement harder to defend. Keeping them separate gives teams clearer controls, audience planning, and a stronger way to show how both efforts support the same brand goal.
2. How can pharma marketing teams make audiences activation-ready with privacy-safe identity?
Pharma teams can make audiences activation-ready by translating fragmented inputs into governed audience workflows that can be matched, activated, separated, and measured. Privacy-safe identity helps prepare DTC and HCP audiences for approved channels and partners while maintaining the separation each workflow requires.
Privacy-safe identity helps prepare DTC and HCP audiences for approved channels and partners while maintaining the separation each workflow requires.
After separating DTC and HCP data, activation, and measurement, the next step is making each audience ready to use across approved channels and partners. Pharma audiences rarely start in a format that is ready for activation across platforms, publishers, and partners. Inputs may come from partner audiences, platform identifiers, CRM systems, privacy-safe consumer signals, HCP attributes, or partner-provided data.
Those inputs need to be translated into usable audiences through governed identity workflows. For DTC campaigns, activation readiness may include cohort construction, non-clinical enrichment, caregiver logic, tokenized matching, and exclusion rules. For HCP campaigns, it may include verified identity inputs such as NPI, specialty, practice location, and professional address.
A strong workflow answers four questions:
- Can the audience be matched accurately?
- Can it be activated across approved destinations?
- Can DTC and HCP separation be maintained?
- Can the audience connect back to verification and measurement?
When the answer is yes, pharma brands have a stronger foundation for audience quality, usable reach, and cross-channel activation.
3. Why should pharma marketers build measurement into the workflow from the start?
Pharma marketers should build measurement into the workflow from the start because campaign exposure needs to connect back to permitted identity frameworks and partner-held outcomes. Planning measurement before activation gives teams a clearer, more explainable way to evaluate how audience strategy, media exposure, and outcomes work together.
Making audiences ready for activation is only one part of the job. Pharma teams also need a clear way to connect media exposure to outcomes, and that measurement plan needs to be in place before a campaign goes live.
Pharma measurement requires more than knowing whether media ran. Brands need to connect exposure signals to permitted identity frameworks and partner-held outcomes in a way that is accurate, governed, and explainable. Those outcomes may include script lift, qualified HCP engagement, audience quality, and exposure-based HCP reporting where appropriate.
Clean rooms and partner-enabled workflows can help connect exposure, identity, and outcomes in a governed way. For DTC campaigns, this may involve linking tokenized audience or exposure data to a measurement partner environment. For HCP campaigns, this may involve resolving exposure back to HCP identity using NPI, professional address, specialty, practice location, partner identifiers, or measurement partner IDs.
When measurement is planned before activation begins, teams gain a clearer view of how audience strategy, media exposure, identity, and outcomes connect.
How does Experian help pharma marketing teams connect identity, activation, and measurement?
Experian helps pharma marketing teams connect identity, activation, and measurement by serving as a neutral, interoperable workflow layer across data, onboarding, approved destinations, and measurement partners. Experian helps teams keep DTC and HCP identity paths separate while preserving the connection between activation and outcomes. Our role centers on three practical needs. We help teams:
As a neutral, interoperable identity, data, and workflow layer, we help brands translate fragmented inputs into activation-ready audiences, connect those audiences to approved destinations, and preserve the structure needed to evaluate performance.
Download Experian’s pharma marketing playbook
These three priorities give pharma teams a place to start. Our full pharma marketing playbook goes deeper into how pharma brands can build privacy-first workflows across onboarding, activation, sequencing, and partner-enabled measurement. Inside the playbook, you’ll find a more detailed look at how to:
- Keep DTC and HCP identity strategies separate
- Prepare audiences for activation across channels
- Evaluate audience quality and governance
- Connect exposure to trusted outcomes through partner-enabled measurement
For pharma marketers working across fragmented data, platforms, and partner ecosystems, our playbook offers a framework for moving from fragmented inputs to more governed activation and stronger measurement readiness. Download our full playbook to learn how privacy-first identity workflows can help pharma brands connect onboarding, activation, and outcomes.
FAQs
Pharma marketers need separate DTC and HCP identity workflows because patients, caregivers, and healthcare professionals require different data signals, activation paths, and measurement methods. Keeping those paths separate helps teams maintain governance while coordinating both efforts toward the same brand objective.
Privacy-safe identity helps pharma marketers translate audience inputs into activation-ready audiences without treating DTC and HCP workflows as one system. It can support tokenized matching, cohort construction, verified HCP identity inputs, and the separation needed to connect activation with trusted outcomes.
Experian helps pharma brands connect data, identity, onboarding, activation, and measurement across a fragmented partner ecosystem. Experian’s identity foundation and workflow connectivity help teams prepare audiences for approved destinations while preserving the structure needed to evaluate trusted outcomes.
Measurement planning should happen before activation begins. When pharma teams define measurement early, they can connect audience strategy, media exposure, identity, and partner-held outcomes in a more accurate, governed, and explainable way.
Pharma marketers should look for audiences that can be matched accurately, activated across approved destinations, kept separate across DTC and HCP workflows, and connected back to verification and measurement. This gives teams a stronger foundation for audience quality, usable reach, and cross-channel activation.
Latest posts
Five Norwegian startups selected to establish U.S. presence NEW YORK, Aug. 15, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has announced its new entrepreneurial mentorship initiative, the Propeller Program. Five early-stage startups from Norway have been chosen by Are Traasdahl, native of Norway and Tapad’s CEO and founder. The selected companies will share Tapad’s New York City workspace, receive C-level guidance and help establish a U.S. presence. The following companies have been selected to participate in the inaugural Propeller Program – a 12-month program beginning September 19, 2016: Bubbly – Developers of a platform that enables in-store customer feedback with dashboards and tools that facilitate real-time store response BylineMe – A marketplace for freelancers, publishers and brands to connect for content creation and distribution services Eventum – A property-sharing group that digitally assists in securing venues for meetings and corporate events Xeneta – A database that organizes the best contracted freight rates in real time and on demand “We are supporting startups that we feel represent the future of service offerings,” said Traasdahl. “It is with incredible pride that we invite these entrepreneurial teams from Norway to join us in New York Citythis year. Mentorship opportunities for early-stage companies are so important, particularly for those based outside the U.S. I look forward to giving the Propeller Program participants access to the expertise of my seasoned team and to our wide network of resources. Hopefully, it will be a game-changing year for many of them.” Contact us today
As partnership deals mount, aggressive hiring underway for unified cross-screen technology leaders NEW YORK, July 19, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has announced plans for aggressive expansion in the Asia Pacific (APAC) region. This move capitalizes on Tapad’s exceptional performance for brands and marketing technology companies in North America and Europe. With it’s proprietary Tapad Device Graph™, the company will enable global, regional and local clients and partners to understand, monetize and measure marketing to users across screens. The Tapad Device Graph is recognized as the most accurate, scalable cross-screen solution in the market today. The decision to expand into APAC was based on increased demand from global, as well as local, brands and clients, many of which have a strong market presence throughout the region. In addition to expanding its roster of world-class data partners, plans include building a world-class team in Singapore. Over the next few months, Tapad APAC will also establish local entities in additional markets. To accelerate its ramp-up, Tapad APAC is actively recruiting in many areas, ranging from skilled and experienced solutions engineers to seasoned sales and marketing professionals. “Tapad is thrilled to be answering the call for cross-device excellence in APAC,” said Pierre Martensson, GM of Tapad APAC. “Our Device Graph is adding millions of devices daily and achieves unmatched levels of scale and accuracy while protecting consumer privacy. This meets a critical need in the region.” Tapad appointed Martensson as General Manager of Tapad APAC in May, kicking off expansion in the region. Martensson comes to Tapad with nearly a decade of operations experience throughout APAC, having transformed, developed and grown global organizations. To learn more about partnership and employment opportunities available with Tapad in APAC, visit www.experian.com/careers. Contact us today
Combined technology gives marketers an enhanced view of the customer for improved planning, targeting and optimization NEW YORK, July 12, 2016/PR Newswire/ – Tapad, the leader in cross-device marketing technology and now a part of Experian, today announced a partnership with Conversion Logic, the martech industry’s most accurate unified marketing attribution provider. Conversion Logic will incorporate unified cross-screen data from Tapad’s Device Graph™ to identify related devices and media exposures to enhance reporting on the path to conversion. By connecting Conversion Logic’s proprietary Ensemble Method, which combines numerous state-of-the-art machine learning algorithms, tuned for each customer use-case for the most accurate results, with Tapad’s unified, cross-device technology, marketers will benefit from a highly scientific approach to assessing advertising effectiveness with full, comprehensive customer insights. Linking these technologies will increase marketers’ real-time ability to optimize brands’ marketing channel spend and creative at a more granular level. During the past six months, Tapad has rapidly grown its data business, doubling the number of companies integrating the Device Graph™ into their platforms and growing the annualized revenue run rate by 210%. Tapad’s highly scalable, cross-device data has been confirmed by Nielsen to be very precise. Tapad augments platforms’ and publishers’ tech stacks with additional scale and relevancy, granting advertisers amplified targeting and analysis options. The growth of the Device GraphTM has allowed Tapad to provide a growing network that benefits all partners with more efficient, effective consumer engagement. “Combining highly accurate data from Tapad with our own user ID technology and understanding how devices may be related at an individual level provides additional visibility into the path to conversion,” said Alison Lohse, COO and co-founder of Conversion Logic. “The more we know about the customer journey, the more effective, efficient and customized marketers can be with marketing efforts. With Tapad, we have achieved a unified customer view that helps us piece together the purchase journey while preserving proven accuracy.” “Conversion Logic’s Ensemble Method delivers singularly customized and precise results that are not just accurate, but actionable,” said Dave Fall, COO of Tapad. “The combination of powerful technology and a user-friendly interface, plus Tapad’s ability to only consider relevant and scalable components in the marketplace, creates a more concentrated and beneficial environment for both its partners and clients.” Contact us today